{
  "id": 1642,
  "text": "1437</td><td>2007</td><td>CCRT (cisplatin)</td><td>CCRT (hydroxyurea)</td><td>OR = 1.50 (95% CI = 1.04-2.16)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (cisplatin)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1437</td><td>2007</td><td>CCRT (cisplatin)</td><td>CCRT (hydroxyurea)</td><td>OR = 1.50 (95% CI = 1.04-2.16)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (cisplatin)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在以顺铂为基础的同步放化疗中，研究表明顺铂单药对宫颈癌的疗效与其与氟尿嘧啶及羟基脲联合使用的疗效相比可能存在差异。文献指出顺铂单药的相对优势有所体现，但联合用药可能提供不同的生物效应机制，提高疗效。因此，选择治疗方案时需权衡单药治疗的副作用与联合治疗的潜在效益，依据患者的具体情况制定个体化治疗方案。",
  "query": "在以顺铂为基础的同步放化疗中，顺铂单药与顺铂、氟尿嘧啶、羟基脲联合使用的疗效比较如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在以顺铂为基础的同步放化疗中，顺铂单药与顺铂、氟尿嘧啶、羟基脲联合使用的疗效比较如何？\n\n<reference text>: 1437</td><td>2007</td><td>CCRT (cisplatin)</td><td>CCRT (hydroxyurea)</td><td>OR = 1.50 (95% CI = 1.04-2.16)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (cisplatin)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在以顺铂为基础的同步放化疗中，研究表明顺铂单药对宫颈癌的疗效与其与氟尿嘧啶及羟基脲联合使用的疗效相比可能存在差异。文献指出顺铂单药的相对优势有所体现，但联合用药可能提供不同的生物效应机制，提高疗效。因此，选择治疗方案时需权衡单药治疗的副作用与联合治疗的潜在效益，依据患者的具体情况制定个体化治疗方案。"
}